• Citer

A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome.

par Morris, Peter E;Papadakos, Peter;Russell, James;Wunderink, Richard;Schuster, Daniel P.;Truwit, Jonathon D;Vincent, Jean Louis ;Bernard, Gordon
Référence Critical care medicine, 36, 3, page (782-788)
Publication Publié, 2008-03

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Acute respiratory distress syndrome is an abrupt inflammatory illness that involves damage from reactive oxygen species. We examined the efficacy and safety of oxothiazolidine-4-carboxylic acid (OTZ), a free radical scavenger, in treating acute respiratory distress syndrome.